ATE476662T1 - Diagnoseverfahren - Google Patents

Diagnoseverfahren

Info

Publication number
ATE476662T1
ATE476662T1 AT98941151T AT98941151T ATE476662T1 AT E476662 T1 ATE476662 T1 AT E476662T1 AT 98941151 T AT98941151 T AT 98941151T AT 98941151 T AT98941151 T AT 98941151T AT E476662 T1 ATE476662 T1 AT E476662T1
Authority
AT
Austria
Prior art keywords
predicting
development
lung damage
damage
diagnosing
Prior art date
Application number
AT98941151T
Other languages
English (en)
Inventor
Ian Doyle
Andrew Bersten
Terence Nicholas
Original Assignee
Southern Medical Diagnostics P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO8999A external-priority patent/AUPO899997A0/en
Priority claimed from AUPP5062A external-priority patent/AUPP506298A0/en
Application filed by Southern Medical Diagnostics P filed Critical Southern Medical Diagnostics P
Application granted granted Critical
Publication of ATE476662T1 publication Critical patent/ATE476662T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vehicle Body Suspensions (AREA)
  • Control Of Eletrric Generators (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT98941151T 1997-09-05 1998-09-04 Diagnoseverfahren ATE476662T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO8999A AUPO899997A0 (en) 1997-09-05 1997-09-05 A method of diagnosis
AUPP5062A AUPP506298A0 (en) 1998-08-04 1998-08-04 A method of diagnosis - II
PCT/AU1998/000723 WO1999013337A1 (en) 1997-09-05 1998-09-04 A method of diagnosis

Publications (1)

Publication Number Publication Date
ATE476662T1 true ATE476662T1 (de) 2010-08-15

Family

ID=25645598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941151T ATE476662T1 (de) 1997-09-05 1998-09-04 Diagnoseverfahren

Country Status (10)

Country Link
US (1) US8097420B1 (de)
EP (1) EP1018018B1 (de)
JP (2) JP4584445B2 (de)
AT (1) ATE476662T1 (de)
CA (1) CA2303169C (de)
DE (1) DE69841804D1 (de)
DK (1) DK1018018T3 (de)
IL (3) IL134880A0 (de)
NZ (1) NZ503175A (de)
WO (1) WO1999013337A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1866378B (zh) 1996-02-28 2010-09-29 松下电器产业株式会社 光盘重放装置
WO2004077056A1 (en) * 2003-02-27 2004-09-10 Lung Health Diagnostics Pty. Ltd. A method of diagnosis and agents useful for same
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1522857A1 (de) * 2003-10-09 2005-04-13 Universiteit Maastricht Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
EP1845379A1 (de) * 2006-04-13 2007-10-17 F. Hoffmann-La Roche AG Mittel und Verfahren zur Differenzierung kardialer und pulmonaler Ursachen von Atemnot
EP1882945A1 (de) * 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Vorrichtungen und Verfahren zur Differentierung zwischen herz- und lungenbedingten Ursachen für akute Atemnot
EP2031397A1 (de) 2007-08-30 2009-03-04 F. Hoffmann-La Roche AG Surfactantproteine B und D bei der Unterscheidung der Ursachen für Atemnot
CN101938939B (zh) * 2008-02-07 2014-11-26 皇家飞利浦电子股份有限公司 用于测量和预测患者呼吸稳定性的装置
EP2689252A1 (de) 2011-03-25 2014-01-29 Roche Diagnostics GmbH Messung von c-terminiertem prosp-b
CN102552879B (zh) * 2012-03-15 2013-11-06 北京双鹤现代医药技术有限责任公司 肺表面活性提取物与肺表面活性物质相关蛋白a的组合物、制备方法及其制药用途
EP2650684A1 (de) 2012-04-10 2013-10-16 Roche Diagniostics GmbH Diagnose auf Pro-SP-B und NT-proBNP bei Patienten mit Lungenentzündung
EP2615459A1 (de) 2012-04-27 2013-07-17 Roche Diagniostics GmbH Verfahren zur Diagnose von Distalbronchoalveolargewebeschäden in Asthma durch Erkennen von proSP-B
EP2866033A1 (de) 2013-10-23 2015-04-29 Roche Diagniostics GmbH Differenzialdiagnose von akuter Atemnot auf Basis von c-terminiertem proSP-B, KL-6 und BNP-Peptiden
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
EP3287921B1 (de) * 2016-08-26 2020-11-04 Nxp B.V. Gesprochener pass-satz zur bestimmung der eignung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650147T2 (de) 1985-05-31 1995-04-06 Teijin Ltd Verfahren zur bestimmung menschlicher lungenoberflächenaktiver substanz und reagenziensatz dazu.
EP0329794B1 (de) 1987-09-01 1994-03-30 Teijin Limited Verfahren zum testen einer wirksamen substanz die sich auf der oberfläche menschlicher lungen befindet
JP2517696B2 (ja) * 1990-04-27 1996-07-24 帝人株式会社 肺疾患マ―カ―蛋白の測定法
DE69214709T2 (de) * 1991-04-26 1997-02-20 Surface Active Ltd Neue Antikörper und Verfahren zu ihrer Verwendung
US5670328A (en) 1992-06-09 1997-09-23 Yamasa Corporation Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof
DE69333283T2 (de) 1992-06-09 2004-08-26 Yamasa Corp., Chishi Lungenkrankheiten screening durch messung der HUMANES OBERFLÄCHENAKTIVES APOPROTEIN D DER LUNGE
ATE292800T1 (de) 1998-07-24 2005-04-15 Altana Pharma Ag Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
US7713705B2 (en) 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof

Also Published As

Publication number Publication date
IL134880A0 (en) 2001-05-20
DK1018018T3 (da) 2010-11-15
WO1999013337A1 (en) 1999-03-18
HK1029622A1 (en) 2001-04-06
JP4584445B2 (ja) 2010-11-24
JP2010197405A (ja) 2010-09-09
EP1018018A1 (de) 2000-07-12
NZ503175A (en) 2002-11-26
IL134880A (en) 2006-12-10
EP1018018A4 (de) 2004-12-22
EP1018018B1 (de) 2010-08-04
CA2303169A1 (en) 1999-03-18
US8097420B1 (en) 2012-01-17
CA2303169C (en) 2009-11-10
IL172185A0 (en) 2009-02-11
JP2001516057A (ja) 2001-09-25
DE69841804D1 (de) 2010-09-16

Similar Documents

Publication Publication Date Title
ATE476662T1 (de) Diagnoseverfahren
FR2847267B1 (fr) Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ATE442592T1 (de) Detektion und/oder beobachtung von synuclein- assoziierten krankheiten
EA199800667A1 (ru) Новые фенантридины
DE60218863D1 (de) Herz-lungen-überwachungsgerät
NO20020837D0 (no) Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer
DE60115940D1 (de) Verfahren und vorrichtung zur beurteilung und verbesserung der leistung eines fahrzeugführers
EA200300387A1 (ru) Ингибиторы рецептора ep4 для лечения ревматоидного артрита
DK0607225T3 (da) Apparat til bestemmelse af den operative effektivitet af et maskinværktøj og fremgangsmåde dertil.
CY1109062T1 (el) Μεθοδοι ανιχνευσεως και αναστολης της αγγειογενεσεως
DE60043152D1 (de) Heilmittel für nierenkrankheiten und verfahren zum screenen selbiger
BR0207548A (pt) Método de controle de poeira automatizado
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
ATE272842T1 (de) Diagnose spongiformer encephalopathie
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DK0647164T3 (da) Planhedsstyring ved båndvalsning
DE69508605D1 (de) Proinsulin-peptid-verbindungen für den nachweis und die behandlung von typ-i-diabetes
CA2091637A1 (en) Call Progress Monitoring
CA2334910A1 (en) New use of a pyridazinone derivative
WO1998041238A3 (en) Methods and kits for treating and diagnosing leiomyomas
DE69532611D1 (de) Mittel zur behandlung von autoimmunkrankheiten
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
DE60127935D1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
KR880701886A (ko) 췌장효소원의 유리활성화 펩티드의 면역검정에 의한 질병의 진단, 위중도 예견, 및 모니터링

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1018018

Country of ref document: EP